An association study of two functional promotor polymorphisms in the myeloperoxidase (MPO) gene in multiple sclerosis

Abstract

Multiple sclerosis (MS) is a chronic neurological disease affecting the central nervous system (CNS). The disease is characterised by demyelination and axonal loss caused by abnormal immunological responses resulting in accumulating neurological disabilities. MS is considered a complex disease, with both genetic and environmental factors contributing to the pathogenesis. In this study, we have investigated the genetic role of the myeloperoxidase (MPO) gene encoding myeloperoxidase in MS. MPO is an enzyme found in myeloid cells which catalyses the production of hypochlorus acid, a potent microbicidal agent. It also plays an important role in inflammatory processes, where migrating neutrophiles may release active MPO and cause tissue damage. In this study, we investigated two polymorphisms located in the promotor region of the MPO gene, known to influence the expression of MPO, in a large case/control material consisting of 871 Swedish MS patients and 532 Swedish healthy controls. No association was observed with risk of MS. Multiple Sclerosis 2007; 13: 697-700. http://msj.sagepub.com

Keywords

association genetics multiple sclerosis myeloperoxidase

Get full access to this article

View all access options for this article.

References

Lassmann H. Neuropathology in multiple sclerosis: new concepts . Mult Scler 1998; 4: 93-98 .

Steinman L. , Waisman A. , Altmann A. Major T-cell responses in multiple sclerosis . Mol Med Today 1995; 1: 79-83 .

Ebers GC , Sadovnick AD The role ofl genetic flactors in multiple sclerosis susceptibility . J Neuroimmunol 1994; 54: 1-17 .

Dyment DA , Ebers GC , Sadovnick AD Genetics ofl multiple sclerosis . Lancet Neurol 2004; 3: 104-10 .

Dyment DA , Yee IM , Ebers GC , Sadovnick AD ; Canadian Collaborative Study Group. Multiple sclerosis in stepsiblings: recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry 2006; 77: 258-59 .

Willer CJ , Dyment DA , Risch NJ , Sadovnick AD , Ebers GC ; Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis . Proc Natl Acad Sci USA 2003; 100: 12877-82 .

Ebers GC , Sadovnick AD , Dyment DA , Yee IM , Willer CJ , Risch NJ Parent-ofl-origin eflflect in multiple sclerosis: observations in halfl-siblings . Lancet 2004; 363: 1773-74 .

Chataway J. , Sawcer S, Feakes , Coraddu F. , Broadley S. , Jones HB et al. A screen ofl candidates flrom peaks ofl linkage: evidence flor the involvement ofl myeloperoxidase in multiple sclerosis . J Neuroimmunol 1999; 98: 208-13 .

Kuokkanen S. , Gschwend M. , Rioux JD , Daly MJ , Terwilliger JD , Tienari PJ et al. Genomewide scan flor multiple sclerosis in Finnish multiplex flamilies . Am J Hum Genet 1997; 61: 1379-87 .

10.

Hoy A. , Leininger-Muller B. , Kutter D. , Siest G. , Visvikis S. Growing significance ofl myeloperoxidase in non-inflectious diseases . Clin Chem Lab Med 2002; 40: 28 .

11.

Piedrafita FJ , Molander RB , Vansant G. , Orlova EA , Pfahl M. , Reynolds WF An Ale element in the myeloperoxidase promotor contains a composite SP1-thyroid hormone-retinoic acid response element . J Biol Chem 1996; 271: 14412-20 .

12.

Nagra RM , Becher B. , Tourtellotte WW , Antel JP , Gold D. , Paladino T. et al. Immunohistochemical and genetic evidence ofl myeloperoxidase involvement in multiple sclerosis . J Neuroimmunol 1997; 78: 97-107 .

13.

Kantarci OH , Atkinson EJ , Hebrink DD , McMurray CT , Weinshenker BG Association ofl a myeloperoxidase promotor polymorphism with multiple sclerosis . J Neuroimmunol 2000; 105: 189-94 .

14.

Zakrzewska-Pniewska B. , Styczynska M. , Podlecka A. , Samocka R. , Peplonska B. , Barcikowska M. et al. Association ofl apolipoprotein E and myeloperoxidase genotypes to clinical course ofl flamilial and sporadic multiple sclerosis . Mult Scler 2004; 10: 266-71 .

15.

Nelissen I. , Fiten P. , Vandenbroeck K. , Hillert J. , Olssson T. , Marrosu MG et al. PECAM 1, MPO and PRKAR1A at chromosome 17q21-q24 a susceptibility flor multiple sclerosis in Sweden and Sardinia . J Neuroimmunol 2000; 108: 153-59 .

16.

Poser CM , Paty DW , Scheinberg L. , McDonald WI , Davis FA , Ebers GC et al. New diagnostic criteria multiple sclerosis: guidelines flor research protocols . Ann Neurol 1983; 13: 227-31 .

17.

McDonald WI , Compston A. , Edan G. , Goodkin D. , Hartung HP , Lublin FD et al. Recommended diagnostic criteria flor multiple sclerosis: guidelines flrom the International Panel on the diagnosis ofl multiple sclerosis . Ann Neurol 2001; 50: 121-27 .

18.

Woolf B. On estimating the relation between blood groups and disease . Ann Hum Genet 1955; 19: 251-53 .